VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53 | -30.3% | 12,155 | +6.4% | 0.00% | – |
| Q2 2023 | $76 | +7.0% | 11,429 | +10.1% | 0.00% | – |
| Q1 2023 | $71 | -100.0% | 10,380 | -97.2% | 0.00% | -100.0% |
| Q1 2015 | $3,400,000 | -94.8% | 365,628 | -92.0% | 0.00% | -92.9% |
| Q4 2014 | $65,517,000 | +53.8% | 4,575,221 | +11.5% | 0.01% | +55.6% |
| Q3 2014 | $42,605,000 | -23.2% | 4,104,521 | +19.8% | 0.01% | -25.0% |
| Q2 2014 | $55,445,000 | +94.8% | 3,426,791 | +95.6% | 0.01% | +100.0% |
| Q1 2014 | $28,468,000 | -5.1% | 1,751,881 | -27.5% | 0.01% | +100.0% |
| Q4 2013 | $29,992,000 | +11661.6% | 2,416,802 | +10317.2% | 0.00% | – |
| Q3 2013 | $255,000 | -44.3% | 23,200 | -59.0% | 0.00% | – |
| Q2 2013 | $458,000 | – | 56,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |